5.44 - 5.64
4.95 - 8.28
2.1K / 2.4K (Avg.)
-272.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-2.80%
Negative revenue growth while UPM.HE stands at 4.80%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-56.27%
Negative gross profit growth while UPM.HE is at 327.43%. Joel Greenblatt would examine cost competitiveness or demand decline.
-80.35%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-80.35%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-70.67%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-69.81%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-69.81%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-2.89%
Share reduction while UPM.HE is at 0.19%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-2.89%
Reduced diluted shares while UPM.HE is at 0.26%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
44.83%
OCF growth at 75-90% of UPM.HE's 54.00%. Bill Ackman would demand better working capital management or cost discipline.
21.40%
FCF growth under 50% of UPM.HE's 80.40%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
-24.72%
Negative 10Y revenue/share CAGR while UPM.HE stands at 2.25%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-24.72%
Negative 5Y CAGR while UPM.HE stands at 16.16%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-8.80%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
65.54%
10Y OCF/share CAGR above 1.5x UPM.HE's 18.26%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
65.54%
5Y OCF/share CAGR above 1.5x UPM.HE's 21.83%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
446.94%
3Y OCF/share CAGR above 1.5x UPM.HE's 46.79%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
108.19%
Positive 10Y CAGR while UPM.HE is negative. John Neff might see a substantial advantage in bottom-line trajectory.
108.19%
Positive 5Y CAGR while UPM.HE is negative. John Neff might view this as a strong mid-term relative advantage.
102.79%
Positive short-term CAGR while UPM.HE is negative. John Neff would see a clear advantage in near-term profit trajectory.
-16.09%
Both are negative. Martin Whitman suspects the segment is in decline or saddled with persistent unprofitability or write-downs.
-16.09%
Negative 5Y equity/share growth while UPM.HE is at 10.79%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
10.00%
Positive short-term equity growth while UPM.HE is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-26.25%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-2.35%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-0.32%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
1.41%
Positive BV/share change while UPM.HE is negative. John Neff sees a clear edge over a competitor losing equity.
-2.90%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-3.26%
We cut SG&A while UPM.HE invests at 0.00%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.